Michael Benkowitz, PRESIDENT AND COO at UNITED THERAPEUTICS Corp (UTHR), sold 45,000 shares at $427.41 ($19.2M) on 2025-10-20, disclosed to the SEC on 2025-10-21.
Scheduled sale ($19.2M) by PRESIDENT AND COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $427.41 | 7,875 | $3.4M | 17.5% |
| 2 | $427.41 | 7,875 | $3.4M | 17.5% |
| 3 | $427.41 | 14,625 | $6.3M | 32.5% |
| 4 | $427.41 | 14,625 | $6.3M | 32.5% |
| Total | $427.41 avg | 45,000 | $19.2M | 100% |
| Filing → |
| UTHR | SELL | 2026-02-10 | $21.4M | — | Filing → |
| UTHR | SELL | 2026-02-03 | $21.2M | — | Filing → |
| UTHR | SELL | 2026-01-28 | $13.5M | — | Filing → |